CAS: 89663-86-5 - lipoxin A4
Formula:C20H32O5
InChI:InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1
InChI key:InChIKey=IXAQOQZEOGMIQS-SSQFXEBMSA-N
SMILES:O=C(O)CCCC(O)C(O)C=CC=CC=CC=CC(O)CCCCC
- Synonyms:
- (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-Trihydroxy-7,9,11,13-eicosatetraenoic acid
- (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
- 5S,6R,15S-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid
- 7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)-
- 7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, [5S-(5R*,6S*,7E,9E,11Z,13E,15R*)]-
- LXA<sub>4</sub>
- Lipoxin A
- Lipoxin A<sub>4</sub>
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lipoxin A4 REF: 7W-GL0256CAS: 89663-86-5 | - - - | To inquire | Tue 17 Dec 24 |
 | Lipoxin A4 REF: 4Z-L-147001CAS: 89663-86-5 | - - - | To inquire | Mon 23 Dec 24 |
 | Lipoxin A4 REF: TM-T36051CAS: 89663-86-5 | 95% | 831.00 €~849.00 € | Thu 02 Jan 25 |
 | Lipoxin A4 REF: 3D-PDA66386CAS: 89663-86-5 | Min. 95% | To inquire | Mon 27 Jan 25 |
Ref: 4Z-L-147001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
Lipoxin A4
CAS:89663-86-5
Lipoxin A4 (LXA4) is an endogenous lipoxygenase-derived arachidonic acid-like mediator with anti-inflammatory properties.
Formula:
C20H32O5
Purity:
95%
Color and Shape:
Liquid
Molecular weight:
352.47
Ref: TM-T36051
| 25µg | 831.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
Lipoxin A4
CAS:89663-86-5
Lipoxin A4 is an inhibitor that has been shown to have potent anticancer activity. It …
Formula:
C20H32O5
Purity:
Min. 95%
Molecular weight:
352.5 g/mol
Ref: 3D-PDA66386
| 10µg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
